Nelson Advisors Partner Lloyd Price invited to speak on the Investor Forum at the Global Health Exhibition 2025 in Riyadh, Saudi Arabia #GHE25 . The Investor Forum at the Global Health Exhibition 2025 is a premier platform for investors, innovators, and healthcare leaders to explore transformative investment opportunities in Saudi Arabia’s rapidly evolving healthcare landscape.

Nelson Advisors partner Lloyd Price interviewed by Digital Health for their 'NHS App to unleash its full potential' story. Lloyd Price, partner at Nelson Advisors and health tech founder, said that the NHS App needs a “killer feature” to increase its usage and “unlock further organic and viral growth”. He added that the main functions of the NHS App to book GP appointments and order repeat prescriptions can be done through other apps such as Patient Access from EMIS, MyGP fr

The European HealthTech market in 2026 is at a pivotal juncture, moving from a period of early-stage experimentation to a more grounded, results-oriented reality. Success for all stakeholders—from innovative founders to strategic buyers—is predicated on navigating a complex and converging landscape defined by regulatory maturation, a selective funding environment, and an accelerated trend of market consolidation. The core thesis of this report is that a strategic shift is req

The global MedTech sector is entering a new era of mergers and acquisitions (M&A) characterised by a pronounced shift from broad portfolio expansion to highly selective, technology-driven acquisitions. While the broader healthcare M&A landscape experienced a decline in deal volume and value in 2024, the MedTech sub-sector demonstrated remarkable resilience. This report highlights that a period of market resurgence is underway, driven by a strategic focus on a smaller number o

Nelson Advisors Partner Lloyd Price has been invited to Judge the 'HealthInvestor Power List 2025 Awards' recognising the most effective, inspiring and influential leaders in Health and Social Care.

The integration of artificial intelligence (AI) into healthcare is not a question of if, but how. This report asserts that for AI to be implemented ethically and effectively, the nursing profession must be at the forefront of its development. Nurses are not merely the end-users of these technologies; they are the indispensable link between raw patient data and human-centered care. By shifting from a traditional technology-first approach to a collaborative, human-in-the-lo

The health technology sector is experiencing a period of intense focus on artificial intelligence, driven by an "AI-first" narrative that has captivated investors and dominated industry discourse. This report posits that this concentrated market behaviour, characterised by an investment "gold rush," presents a profound opportunity for a contrarian business strategy. The prevailing AI narrative, much like other market frenzies, has led to a collective overvaluation of a single

The global HealthTech landscape is undergoing a profound structural transformation. A confluence of economic headwinds in mature markets, particularly in North America and a recalibration of investor sentiment away from speculative growth has positioned cross-border mergers and acquisitions (M&A) as the primary engine of strategic growth and liquidity. This report presents a detailed analysis of this new paradigm, arguing that strategic buyers, from big Pharma and health

Nelson Advisors specialise in mergers and acquisitions, partnerships and investments for MedTech companies in the UK, Europe and USA...

Nelson Advisors featured in the PMLiVE article 'The digital prescription: enhancing the patient experience with technology' Nelson...

Nelson Advisors thought leadership blog 'Healthcare.Digital' has featured in the Tony Blair Institute for Global Change publication 'The NHS at a Crossroads: The App That Can Transform Britain’s Health' highlighting the scale and importance of Doctolib in the French HealthTech market.

The healthcare industry is in the midst of a profound transformation, driven by the convergence of digital platforms, a growing abundance of health data, and the analytical power of artificial intelligence (AI). This shift is not merely an incremental improvement but a fundamental re-architecture of care delivery, moving toward models that are more proactive, personalised, and efficient. The market for these technologies is expanding at an unprecedented rate, creating a clear

The speculative "gold rush" in healthcare artificial intelligence, characterised by a feverish pace of unbridled investment and a technology-first approach to product development, has concluded. A new, more discerning market has emerged, defined not by the promise of an algorithm but by a strategic fusion of technological efficacy, market access, and quantifiable value. This report provides a detailed analysis of this new equilibrium. The distinction between "thrivers" an

The MedTech sector in 2026 stands at a pivotal juncture, defined by the convergence of rapid technological innovation, a maturing market demanding proven value, and a complex policy landscape. This report synthesizes these forces, moving from a macro-level analysis to specific, actionable insights. The industry is shifting from a focus on siloed technological advancements to an integrated, interconnected ecosystem where success hinges on the ability to operationalise innovati

The analysis of Nelson Advisors reveals a sophisticated and highly specialised boutique investment banking firm whose value proposition is built on a unique confluence of expertise. The firm's exclusive focus on the European HealthTech sector is a powerful competitive differentiator, allowing it to provide a level of nuanced, industry-specific advisory that generalist firms cannot match. The "Founders for Founders" approach, which is the cornerstone of its identity, is a stra